Top

Published in:

Open Access 01-12-2021 | Checkpoint Inhibitors | Correction

Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Authors: Xiaobin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang

Published in: Cancer Cell International | Issue 1/2021

Excerpt

In this article [1], the author name “Xiaobin Wu” was incorrectly written as “Xianbin Wu”. This has been corrected in this correction. …

Wu X, Han R, Zhong Y, Weng N, Zhang A. Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma. Cancer Cell Int. 2021;21:356. https://doi.org/10.1186/s12935-021-02072-x.CrossRefPubMedPubMedCentral

Title: Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Authors: Xiaobin Wu
Runkun Han
Yanping Zhong
Nuoqing Weng
Ao Zhang
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Checkpoint Inhibitors
Published in: Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-021-02401-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Long non-coding RNA HEIH: a novel tumor activator in multiple cancers

CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis

circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis

The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer